Skin and Soft Tissue Infection
📧 Sign up to get email alerts when something new happens for Skin and Soft Tissue Infection.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2026-04-07FDA Approved: CEFEPIME HYDROCHLORIDE AND DEXTROSE — Supplemental Application (B. Braun Medical Inc.)
FDA approved a supplemental application from B. Braun Medical Inc. for Cefepime hydrochloride and dextrose, adding this formulation under th…
-
FDA approval · 2020-09-09FDA Approved: CEFTRIAXONE AND DEXTROSE — Supplemental Application (B. Braun Medical Inc.)
FDA approved a supplemental application for Ceftriaxone and Dextrose from B. Braun Medical, resulting in an updated/expanded approval for th…
-
FDA approval · 2020-01-27FDA Approved: AMOXICILLIN AND CLAVULANATE POTASSIUM — Supplemental Application (Sandoz Inc)
The FDA approved a supplemental application for Amoxicillin and clavulanate potassium by Sandoz Inc.
-
FDA approval · 2012-02-17FDA Approved: CEFACLOR — Original Application (Azorian Pharma, LLC)
The FDA approved Azorian Pharma, LLC's original application for Cefaclor (generic) for treating susceptible bacterial infections including r…
-
FDA approval · 2010-11-29FDA Approved: CEFAZOLIN — Supplemental Application (Fresenius Kabi USA, LLC)
The FDA approved a supplemental application for Cefazolin (cefazolin sodium) from Fresenius Kabi USA, LLC, updating an already approved prod…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2010-10-21FDA Approved: PIPERACILLIN AND TAZOBACTAM — Original Application (Hospira, Inc)
FDA approved Hospira's piperacillin/tazobactam combination under an original ANDA application, providing a generic version of the antibiotic…
-
FDA approval · 2010-03-12FDA Approved: CEFOXITIN — Original Application (Hikma Pharmaceuticals USA Inc.)
The FDA approved an original ANDA for cefoxitin by Hikma Pharmaceuticals USA, enabling a generic version of cefoxitin for its indicated infe…
-
FDA approval · 2009-12-22FDA Approved: AMPICILLIN AND SULBACTAM — Original Application (Hikma Pharmaceuticals USA Inc.)
FDA approved Hikma's Ampicillin and Sulbactam as an Original Application (AND A065406), a generic antibiotic combining ampicillin with sulba…
-
FDA approval · 2007-11-09FDA Approved: AMOXICILLIN AND CLAVULANATE POTASSIUM — Original Application (Hikma Pharmaceuticals USA Inc.)
The FDA approved Hikma Pharmaceuticals USA Inc.'s generic amoxicillin and clavulanate potassium under an Original Application.
-
FDA approval · 2007-03-26FDA Approved: AMOXICILLIN — Original Application (Sandoz Inc)
FDA approved Sandoz Inc's original application for amoxicillin, making a generic amoxicillin product available. The approval supports its us…
-
FDA approval · 2006-06-19FDA Approved: AMOXICILLIN — Original Application (Hikma Pharmaceuticals USA Inc.)
FDA approved Hikma Pharmaceuticals USA Inc. to market amoxicillin under an Original Application (ANDA). The approval covers a generic amoxic…